Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Curative Biotechnology Inc (CUBT)

Curative Biotechnology Inc (CUBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,705
  • Shares Outstanding, K 1,022,763
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,605 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 11/14/25
  • Next Earnings Date 04/21/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0030 +53.33%
on 12/31/25
0.0095 -51.58%
on 12/22/25
-0.0032 (-41.03%)
since 12/12/25
3-Month
0.0030 +53.33%
on 12/31/25
0.0105 -56.19%
on 11/18/25
-0.0026 (-36.11%)
since 10/10/25
52-Week
0.0030 +53.33%
on 12/31/25
0.0288 -84.03%
on 03/07/25
-0.0087 (-65.41%)
since 01/10/25

Most Recent Stories

More News
Curative Biotechnology, Inc. Announces Letter to Shareholders

Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”),...

CUBT : 0.0046 (unch)
Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor

CUBT : 0.0046 (unch)
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors

Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC:...

OTC.VN : 0.550 (-1.79%)
CUBT : 0.0046 (unch)
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors

Appointment of Independent Director Adds to Financial Expertise on Board Boca Raton, FL, May 12, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc....

OTC.VN : 0.550 (-1.79%)
CUBT : 0.0046 (unch)
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May ...

OTC.VN : 0.550 (-1.79%)
CUBT : 0.0046 (unch)
Curative Biotechnology Announces Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration

Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator Boca Raton, FL, March 21, 2022 (GLOBE NEWSWIRE) -- Curative...

OTC.VN : 0.550 (-1.79%)
CUBT : 0.0046 (unch)

Business Summary

Curative Biotechnology Inc. is a development-stage biomedical company focusing on novel treatments for rare diseases. The company is focused on therapies with potentially accelerated development paths as a result of either the disease, the nature of the therapeutic itself or the stage of clinical development....

See More

Key Turning Points

3rd Resistance Point 0.0061
2nd Resistance Point 0.0054
1st Resistance Point 0.0050
Last Price 0.0046
1st Support Level 0.0039
2nd Support Level 0.0032
3rd Support Level 0.0028

See More

52-Week High 0.0288
Fibonacci 61.8% 0.0189
Fibonacci 50% 0.0159
Fibonacci 38.2% 0.0129
Last Price 0.0046
52-Week Low 0.0030

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar